Non-Invasive Evaluation of the GABAergic/Glutamatergic System in Autistic Patients Observed by MEGA-Editing Proton MR Spectroscopy Using a Clinical 3 Tesla Instrument
The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
Amino acids related to neurotransmitters and the GABAergic/glutamatergic system were measured using a 3 T-MRI instrument in 12 patients with autism and 10 normal controls. All measurements were performed in the frontal lobe (FL) and lenticular nuclei (LN) using a conventional sequence for n-acetyl aspartate (NAA) and glutamate (Glu), and the MEGA-editing method for GABA. The GABA level and [GABA]/[NAA] ratio were significantly lower (p < 0.01) in the FL, but not the LN, in patients with autism compared to normal controls. The [GABA]/[Glu] ratio in the FL was also significantly lower (p < 0.05) in the patients than in the normal controls, thus suggesting a possible abnormality in the regulation between GABA and Glu.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“while in CNTNAP2 deficient mice a decreased ratio of GABA to glutamate is seen in the medial prefrontal cortex (Selimbeyoglu et al. 2017), a finding paralleling results in autism patients (Harada et al. 2011).”
From Dysfunctional Autism Risk Genes Cause Circuit-Specific Connectivity Deficits With Distinct Developmental Trajectories (2018) · cites this paper as Harada et al. 2011
Citations
Cites
Estimation of metabolite concentrations from localized in vivo proton NMR spectra
Provencher, S. W. (1993) · Magnetic Resonance in Medicine · doi:10.1002/mrm.1910300604 · Cited by 3,655 · cited 1×
“To increase the reliability of the signals from GABA, the MEGA-editing J difference technique was applied to a 3 T instrument (Meshcer et al. 1998) and the obtained spectra were analyzed by the LCModel software package ( Provencher 1993 ) using our original basis set for the MEGAediting method.”
MethodSimultaneousin vivo spectral editing and water suppression
Mescher, M., Merkle, H., Kirsch, J., Garwood, M., & Gruetter, R. (1998) · NMR in Biomedicine · doi:10.1002/(sici)1099-1492(199810)11:6<266::aid-nbm530>3.0.co;2-j · Cited by 1,015
Histoanatomic observations of the brain in early infantile autism
Bauman, M., & Kemper, T. L. (1985) · Neurology · doi:10.1212/wnl.35.6.866 · Cited by 964
American Academy of Pediatrics, American Academy of Pediatric Dentistry, Coté, C. J., Wilson, S., & the Work Group on Sedation (2006) · Pediatrics · doi:10.1542/peds.2006-2780 · Cited by 555
Fatemi, S. H., Halt, A. R., Stary, J. M., Kanodia, R., Schulz, S. C., & Realmuto, G. R. (2002) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01430-0 · Cited by 500 · cited 2×
“Fatemi et al. (2002) showed a reduction of the GAD 65- and 67-kDa proteins in autistic parietal and cerebellar cortices, and Aldred et al. (2003) and Shinohe et al. (2006) demonstrated the presence of a high level of glutamic acid in patients’ serum.”
BackgroundGABAA Receptor Downregulation in Brains of Subjects with Autism
Fatemi, S. H., Reutiman, T. J., Folsom, T. D., & Thuras, P. D. (2009) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-008-0646-7 · Cited by 439 · cited 2×
“Our study demonstrated a low level of GABA in the FL in patients with autism, which seems to be consistent with the results of the study on the reduction of GABAA and GABAB receptors by Fatemi et al. (2008, 2009) .”
ResultSamaco, R. C., Hogart, A., & LaSalle, J. M. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi045 · Cited by 421
N-Acetylaspartate in the Vertebrate Brain: Metabolism and Function
Baslow, M. H. (2003) · Neurochemical Research · doi:10.1023/a:1023250721185 · Cited by 392 · cited 1×
“It is known that the quantified values of NAA from conventional proton MRS reflect the neuronal density ( Baslow 2003 ).”
BackgroundLinkage-disequilibrium mapping of autistic disorder, with 15q11-13 markers
Cook, E. H., Courchesne, R. Y., Cox, N. J., Lord, C., Gonen, D., Guter, S. J., Lincoln, A., Nix, K., Haas, R., Leventhal, B. L., et al. (1998) · The American Journal of Human Genetics · doi:10.1086/301832 · Cited by 369 · cited 1×
“Although there have been several MRS studies of GABA measurement which involved tissue separation (Petroff et al. 1988; Jensen et al. 2005; Choi et al. 2006, 2007 ), the ratio between the gray and white matter showed a large variation, from 1.8 to 8.1.”
BackgroundInfluentialMa, D. Q., Whitehead, P. L., Menold, M. M., Martin, E. R., Ashley-Koch, A. E., Mei, H., Ritchie, M. D., DeLong, G. R., Abramson, R. K., Wright, H. H., et al. (2005) · The American Journal of Human Genetics · doi:10.1086/433195 · Cited by 354
Neurochemical correlates of autistic disorder: a review of the literature
Lam, K. S. L., Aman, M. G., & Arnold, L. E. (2006) · Research in Developmental Disabilities · doi:10.1016/j.ridd.2005.03.003 · Cited by 318
Pouwels, P. J. W., Brockmann, K., Kruse, B., Wilken, B., Wick, M., Hanefeld, F., & Frahm, J. (1999) · Pediatric Research · doi:10.1203/00006450-199910000-00019 · Cited by 309
Increased serum levels of glutamate in adult patients with autism
Shinohe, A., Hashimoto, K., Nakamura, K., Tsujii, M., Iwata, Y., Tsuchiya, K. J., Sekine, Y., Suda, S., Suzuki, K., Sugihara, G.-I., et al. (2006) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2006.06.013 · Cited by 234 · cited 1×
“After Cook et al. (1998) found an abnormality in the GABA receptor subunit gene in autistic disorder, an epigenetic overlap and a gene‐gene interaction of the GABA receptor subunit genes in autism were reported by Samaco et al. (2004) and Ma et al. (2005).”
BackgroundExpression of GABAB Receptors Is Altered in Brains of Subjects with Autism
Fatemi, S. H., Folsom, T. D., Reutiman, T. J., & Thuras, P. D. (2009) · The Cerebellum · doi:10.1007/s12311-008-0075-3 · Cited by 227 · cited 2×
“Our study demonstrated a low level of GABA in the FL in patients with autism, which seems to be consistent with the results of the study on the reduction of GABAA and GABAB receptors by Fatemi et al. (2008, 2009) .”
Result(2008) · Pediatric Anesthesia · doi:10.1111/j.1460-9592.2007.02404.x · Cited by 216
Plasma amino acid levels in children with autism and their families
Aldred, S., Moore, K. M., Fitzgerald, M., & Waring, R. H. (2003) · Journal of Autism and Developmental Disorders · doi:10.1023/a:1022238706604 · Cited by 188 · cited 1×
“Fatemi et al. (2002) showed a reduction of the GAD 65- and 67-kDa proteins in autistic parietal and cerebellar cortices, and Aldred et al. (2003) and Shinohe et al. (2006) demonstrated the presence of a high level of glutamic acid in patients’ serum.”
BackgroundPetroff, O. A. C., Ogino, T., & Alger, J. R. (1988) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1988.tb04850.x · Cited by 187 · cited 2×
“Although there have been several MRS studies of GABA measurement which involved tissue separation ( Petroff et al. 1988; Jensen et al. 2005; Choi et al. 2006, 2007), the ratio between the gray and white matter showed a large variation, from 1.8 to 8.1.”
BackgroundMethodInfluentialRegional brain chemical alterations in young children with autism spectrum disorder
Friedman, S. D., Shaw, D. W., Artru, A. A., Richards, T. L., Gardner, J., Dawson, G., Posse, S., & Dager, S. R. (2003) · Neurology · doi:10.1212/wnl.60.1.100 · Cited by 179
Plasma Amino Acids Profiles in Children with Autism: Potential Risk of Nutritional Deficiencies
Arnold, G. L., Hyman, S. L., Mooney, R. A., & Kirby, R. S. (2003) · Journal of Autism and Developmental Disorders · doi:10.1023/a:1025071014191 · Cited by 176
Terpstra, M., Henry, P., & Gruetter, R. (2003) · Magnetic Resonance in Medicine · doi:10.1002/mrm.10499 · Cited by 175 · cited 2×
“Terpstra et al. (2002, 2003) showed the proportion of MM contamination to the total edited signal for GABA to only be 15% and that the post-processing using LCModel could diminish the MM contamination.”
MethodResultPage, L. A., Daly, E., Schmitz, N., Simmons, A., Toal, F., Deeley, Q., Ambery, F., McAlonan, G. M., Murphy, K. C., & Murphy, D. G. M. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.12.2189 · Cited by 157
Evidence for Cortical Dysfunction in Autism: A Proton Magnetic Resonance Spectroscopic Imaging Study
DeVito, T. J., Drost, D. J., Neufeld, R. W. J., Rajakumar, N., Pavlosky, W. F., Williamson, P., & Nicolson, R. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.07.022 · Cited by 155
Gray and White Matter Brain Chemistry in Young Children With Autism
Friedman, S. D., Shaw, D. W. W., Artru, A. A., Dawson, G., Petropoulos, H., & Dager, S. R. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.7.786 · Cited by 139 · cited 1×
“However, although Friedman et al. (2006) reported that T2 relaxation of Cho was prolonged in the gray matter of autistic patients compared to normal controls, they did not show significant a difference in NAA and Cr between the two groups.”
BackgroundAsperger Syndrome: A Proton Magnetic Resonance Spectroscopy Study of Brain
Murphy, D. G. M., Critchley, H. D., Schmitz, N., McAlonan, G., van Amelsvoort, T., Robertson, D., Daly, E., Rowe, A., Russell, A., Simmons, A., et al. (2002) · Archives of General Psychiatry · doi:10.1001/archpsyc.59.10.885 · Cited by 139
Direct in vivo measurement of human cerebral GABA concentration using MEGA‐editing at 7 Tesla
Terpstra, M., Ugurbil, K., & Gruetter, R. (2002) · Magnetic Resonance in Medicine · doi:10.1002/mrm.10146 · Cited by 130 · cited 1×
“Terpstra et al. (2002, 2003) showed the proportion of MM contamination to the total edited signal for GABA to only be 15% and that the post-processing using LCModel could diminish the MM contamination.”
MethodOtsuka, H., Harada, M., Mori, K., Hisaoka, S., & Nishitani, H. (1999) · Neuroradiology · doi:10.1007/s002340050795 · Cited by 117
Self-citationJensen, J. E., deB. Frederick, B., & Renshaw, P. F. (2005) · NMR in Biomedicine · doi:10.1002/nbm.994 · Cited by 115 · cited 1×
“Although there have been several MRS studies of GABA measurement which involved tissue separation (Petroff et al. 1988; Jensen et al. 2005; Choi et al. 2006, 2007), the ratio between the gray and white matter showed a large variation, from 1.8 to 8.1.”
BackgroundInfluentialThe Neurobiology and Genetics of Infantile Autism
Lotspeich, L. J., & Ciaranello, R. D. (1993) · International review of neurobiology · doi:10.1016/s0074-7742(08)60569-3 · Cited by 112
Proton magnetic resonance spectroscopic imaging of the brain in childhood autism
Levitt, J. G., O’Neill, J., Blanton, R. E., Smalley, S. L., Fadale, D., McCracken, J. T., Guthrie, D., Toga, A. W., & Alger, J. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00688-7 · Cited by 110 · cited 1×
“hypothesis that the GABAergic system is suppressed, resulting in excessive stimulation of the glutamate system ( Lam et al. 2006 ).”
BackgroundÖz, G., Terpstra, M., Tkáč, I., Aia, P., Lowary, J., Tuite, P. J., & Gruetter, R. (2006) · Magnetic Resonance in Medicine · doi:10.1002/mrm.20761 · Cited by 106
Petroff, O. A. C., Rothman, D. L., Behar, K. L., & Mattson, R. H. (1995) · Epilepsia · doi:10.1111/j.1528-1157.1995.tb00486.x · Cited by 100 · cited 1×
“There are several reports that vigabatrin increases the brain GABA level by inhibiting GABA transaminase ( Petroff et al. 1995, 1996; Weber et al. 1999; Novotny et al. 1999) although triclofos sodium does not change the activity of this enzyme.”
BackgroundHarada, M., Kubo, H., Nose, A., Nishitani, H., & Matsuda, T. (2011) · Human Brain Mapping · doi:10.1002/hbm.21086 · Cited by 92
Self-citationIn vivo detection of gray and white matter differences in GABA concentration in the human brain
Choi, I.-Y., Lee, P., Merkle, H., & Shen, J. (2006) · NeuroImage · doi:10.1016/j.neuroimage.2006.06.016 · Cited by 87
Petroff, O. A. C., Behar, K. L., Mattson, R. H., & Rothman, D. L. (1996) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1996.67062399.x · Cited by 86 · cited 1×
“There are several reports that vigabatrin increases the brain GABA level by inhibiting GABA transaminase ( Petroff et al. 1995, 1996; Weber et al. 1999; Novotny et al. 1999) although triclofos sodium does not change the activity of this enzyme.”
BackgroundGuptill, J. T., Booker, A. B., Gibbs, T. T., Kemper, T. L., Bauman, M. L., & Blatt, G. J. (2006) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-006-0226-7 · Cited by 74 · cited 1×
“Recently, the downregulation or alteration of both the GABAA and GABAB receptors in subjects with autism was reported (Fatemi et al. 2008, 2009), and an autoradiographic study using the [3H]flunitrazepam-labeled benzodiazepine site also suggested there is an alteration in the modulation of the GABAA receptors in the a…”
ResultMagnetic resonance imaging of superficial cartilage lesions: Role of contrast in lesion detection
Mosher, T. J., & Pruett, S. W. (1999) · Journal of Magnetic Resonance Imaging · doi:10.1002/(sici)1522-2586(199908)10:2<124::aid-jmri3>3.0.co;2-t · Cited by 73 · cited 1×
“An examination of the test‐retest reliability to measure the GABA level in the brain was conducted ahead of this clinical study and the reproducibility was considered to be acceptable as a clinical investigation, showing an intraclass correlation coefficient of 0.72 ( Harada et al. in press ).”
MethodInfluentialRegional magnetic resonance spectroscopy of the brain in autistic individuals
Hisaoka, S., Harada, M., Nishitani, H., & Mori, K. (2001) · Neuroradiology · doi:10.1007/s002340000520 · Cited by 55 · cited 1×
“The observation of metabolites in patients with autism using proton MRS has thus far been studied by our group (Otsuka et al. 1999; Hisaoka et al. 2001 ) and by Levitt et al. (2003) and Friedman et al. (2003).”
MethodSelf-citationProton magnetic resonance spectroscopy of brain biopsies from patients with intractable epilepsy
Aasly, J. O., SILFVENIUS, H., Aas, T. C., Sonnewald, U., Olivecrona, M., Juul, R., & White, L. R. (1999) · Epilepsy Research · doi:10.1016/s0920-1211(99)00011-x · Cited by 51
Weber, O. M., Verhagen, A. F. T. M., Duc, C. O., Meier, D., Leenders, K. L., & Boesiger, P. (1999) · Magnetic Resonance Imaging · doi:10.1016/s0730-725x(98)00184-2 · Cited by 50 · cited 1×
“There are several reports that vigabatrin increases the brain GABA level by inhibiting GABA transaminase (Petroff et al. 1995, 1996; Weber et al. 1999; Novotny et al. 1999) although triclofos sodium does not change the activity of this enzyme.”
BackgroundMeasurement of GABA and contaminants in gray and white matter in human brain in vivo
Choi, C., Bhardwaj, P. P., Kalra, S., Casault, C. A., Yasmin, U. S., Allen, P. S., & Coupland, N. J. (2007) · Magnetic Resonance in Medicine · doi:10.1002/mrm.21275 · Cited by 35 · cited 1×
“Neuroanatomically, autistic individuals demonstrate a loss of pyramidal neurons in the frontal cortex, limbic system abnormalities and a significant loss of Purkinje cells in the cerebellum ( Bauman and Kemper 1985; Lotspeich and Ciaranello 1993).”
BackgroundGABA Changes with Vigabatrin in the Developing Human Brain
Novotny, E. J., Hyder, F., Shevell, M., & Rothman, D. L. (1999) · Epilepsia · doi:10.1111/j.1528-1157.1999.tb00741.x · Cited by 30 · cited 1×
“There are several reports that vigabatrin increases the brain GABA level by inhibiting GABA transaminase (Petroff et al. 1995, 1996; Weber et al. 1999; Novotny et al. 1999 ) although triclofos sodium does not change the activity of this enzyme.”
Background
Cited by
Ferguson, B. R., & Gao, W.-J. (2018) · Frontiers in Neural Circuits · doi:10.3389/fncir.2018.00037 · Cited by 594
“Supporting this are in vivo findings of reduced GABA and GABAAR levels in the frontal cortex of autistic patients (Harada et al., 2011; Mori et al., 2012), along with reductions in gamma oscillations (Sun et al., 2012).”
BackgroundGABA system dysfunction in autism and related disorders: From synapse to symptoms
Coghlan, S., Horder, J., Inkster, B., Mendez, M. A., Murphy, D. G., & Nutt, D. J. (2012) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2012.07.005 · Cited by 446
Schür, R. R., Draisma, L. W. R., Wijnen, J. P., Boks, M. P., Koevoets, M. G. J. C., Joëls, M., Klomp, D. W., Kahn, R. S., & Vinkers, C. H. (2016) · Human Brain Mapping · doi:10.1002/hbm.23244 · Cited by 349
“, 2010], autism spectrum disorder (ASD) (N 5 5) [Brix et al., 2015; Cochran et al., 2015; Gaetz et al., 2014; Harada et al., 2011; Rojas et al., 2014], bipolar disorder (N 5 4) [Bhagwagar et al.”
BackgroundMethodInfluentialSelimbeyoglu, A., Kim, C. K., Inoue, M., Lee, S. Y., Hong, A. S. O., Kauvar, I., Ramakrishnan, C., Fenno, L. E., Davidson, T. J., Wright, M., et al. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aah6733 · Cited by 326
“Supporting evidence for this concept includes observations in postmortem human brain tissue of a decreased number of parvalbumin (PV) neurons in the medial prefrontal cortex (mPFC) (8), a decreased expression ofmRNAs encoding receptors for the inhibitory neurotransmitter g-aminobutyric acid (GABA) (9), a decreased rat…”
BackgroundHorder, J., Petrinovic, M. M., Mendez, M. A., Bruns, A., Takumi, T., Spooren, W., Barker, G. J., Künnecke, B., & Murphy, D. G. (2018) · Translational Psychiatry · doi:10.1038/s41398-018-0155-1 · Cited by 309
Metadata
- Authors
- Harada, M., Taki, M. M., Nose, A., Kubo, H., Mori, K., Nishitani, H., & Matsuda, T.
- Affiliations
- Tokushima University (JP)
- GE HealthCare (Japan) (JP)
- Corresponding author
- Harada, Masafumi
- Venue
- Journal of Autism and Developmental Disorders
- Published
- 2010-07-21
- Volume
- 41
- Issue
- 4
- Pages
- 447-454
- ISSN
- 0162-3257 (ISSN-L)
- 1573-3432
- OpenAlex
- W2144632316
- Cited by
- 231
- References
- 41
- Citations by year
- 2026: 1 · 2025: 12 · 2024: 16 · 2023: 14 · 2022: 10 · 2021: 18 · 2020: 14 · 2019: 10 · 2018: 17 · 2017: 18 · 2016: 18 · 2015: 22 · 2014: 21 · 2013: 15 · 2012: 11
- FWCI
- 7.76
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Journal of Autism and Developmental Disorders (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cognitive Neuroscience › Autism Spectrum Disorder Research
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Advanced MRI Techniques and Applications
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
- Keywords
- autism spectrum disorder, GABA, glutamate, 1H NMR, N-acetylaspartate, frontal lobe, lenticular nuclei, GABA/glutamate ratio, neurotransmitter metabolism
- MeSH terms
- Analysis of Variance, Aspartic Acid, Autistic Disorder, Child, Child, Preschool, Corpus Striatum, Frontal Lobe, gamma-Aminobutyric Acid, Humans, Magnetic Resonance Spectroscopy, Glutamic Acid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.